CM Management’s Filana Therapeutics FLNA Stock Holding History

CM Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-175,000	Closed	-$1.19M	–	94
2020 Q4	$1.19M	Buy	+175,000	New	+$1.56M	1.11%	29

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CM Management's FLNA Position: Q1 2021 in Review

CM Management sold out of Filana Therapeutics (FLNA) in Q1 2021, closing a stake of 175,000 shares — an estimated $1.19M sold.

CM Management first reported a position in FLNA in Q4 2020 and held it in 1 quarter. The position peaked at $1.19M in Q4 2020. 128 funds tracked by Wall St. Rank hold FLNA as of Q1 2021.

CM Management reported no remaining Filana Therapeutics position as of Q1 2021 after selling out during the quarter.
CM Management sold 175,000 Filana Therapeutics shares in Q1 2021, an estimated $1.19M.
CM Management first reported a position in Filana Therapeutics in Q4 2020 and held it in 1 quarter.
CM Management's Filana Therapeutics position peaked at $1.19M in Q4 2020.
128 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2021.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.